Key result
This review summarizes the epidemiology, classification, mechanisms of development, and therapy of atrial fibrillation in heart transplant recipients.
This review summarizes the epidemiology, mechanisms, and management of atrial fibrillation in heart transplant recipients, highlighting its potential to cause cardioembolic complications.
May guide consideration of AF post-heart transplant; leaves open prospective trials to define optimal therapy.
Arrhythmias in heart transplant recipients remain an important but under-studied issue in transplant medicine. One of the most common arrhythmias, atrial fibrillation can cause cardioembolic complications in transplant recipients, in the same way as in general population and, accordingly, affect the quality of life and the prognosis. This review discusses epidemiology, classification, mechanisms of development, and therapy of atrial fibrillation after heart transplantation.
No takes yet. Share an insight, caveat, or question.
Lepshokova et al. (2018) conducted a review in Atrial fibrillation after heart transplantation. Atrial fibrillation was evaluated. This review summarizes the epidemiology, classification, mechanisms of development, and therapy of atrial fibrillation in heart transplant recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: